The choice of new technologies possessing the potential to replace (or at least augment) traditional "gold standard" culture and serological methods in microbiological research and diagnostic laboratories is surprisingly large, with most of these new technologies having been developed into commercially viable options within the previous 10 years. Bearing this in mind, the authors have attempted to include in this ebook primer, a broad range of chapters describing innovative new technologies that are being/have been developed within several different fields of scientific research. These fields include nano-culture, nucleic acid amplification and detection (genomics), protein-based detection (proteomics), growth and metabolism (metabolomics), and immunological/serological markers. Further, the authors of each chapter have included descriptions of how their technology is being/may be used in both theory and practice within medical microbiological diagnosis and research, including relevant lists of references.
In Chapter 1, Ingham and Schneeberger discuss a new technology that take the traditional approach to microbiological research and diagnosis (with its emphasis on the selective culture to obtain pure microbial colonies) a step further. They describe the advantages associated with new nanoporous materials (especially porous aluminium oxide or PAO), and their use in the development of highly subdivided microbial culture chips, with up to a million separate, miniaturized growth areas. Chapters 2 and 3 describe new technologies associated with proteins and proteomics and their use in medical microbiological diagnostics. In Chapter 2, Hwang et al., describe recent advances in peptide-based probes and biosensor technology, including methods associated with mass perturbance, electrical perturbance, and optical methods. Special emphasis is placed on the possible impact of peptide-based biosensors in pandemic disease surveillance. Martin Welker in Chapter 3 explains the technique of Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) and its potential application in rapidly identifying microorganisms and cellular components, including the advantages and disadvantages of this new technology in microbial identification and taxonomy.
The field of metabolomics and metabolomic-related technology is described in Chapters 4 and 5, Guazzaroni et al., provide a general overview of the techniques, problems and prospects encountered in the analysis of small metabolite compounds. One of their objectives is to provide the reader with information on how (meta-) metabolomic fingerprinting studies can be used to assess microbial community and microbe-host interactions. In a similar manner, Bruins et al., provide a brief overview of the problems and recent technological developments associated with the development of 'electronic nose' technology, with particular emphasis on their own company's technology. Their embryonic electronic nose technology monitors the production of volatile metabolic molecules during bacterial growth.
The use of nanoparticles in medical microbiological research and diagnosis is described in Chapter 6, where Ikonomopoulis et al., explain the possible uses of nanoparticles (conjugated to oligonucleotide, antibodies and peptides) in identifying the genetic or immunogenic footprint of pathogens. Manmohan et al. in Chapter 7, describe the potential use of a novel DNA nucleic acid amplification system (Loop Mediated Isothermal Amplification or LAMP) as a tool that offers rapid, accurate, and cost-effective diagnosis for infectious diseases. This technology has already been developed into several commercial kits, but the full potential of this technology has yet to be realised.
iii In chapter 8, Nuutila describes recent research investigating the use of flow cytometric quantitative analysis in the detection of new specific and sensitive phagocytic cell surface markers. He shows how these findings may be incorporated into novel algorithms in order to rapidly determine the presence/absence of bacterial or viral infections in hospitalised patients. In Chapter 9, Verkaik et al., provide a brief description of the Luminex bead-based flow cytometry technique, which allows the simultaneous quantification of multiple antibodies antigens (or oligonucleotide) in a single sample. They include an example of how this technology is being used to determine the importance of IgG immunoglobulin levels in Staphylococcus aureus colonisation.
Finally, the editors predict that advances in at least some of the 'new technologies' described in this e-Book 'primer', will eventually be developed into successful 'point-of-care' or 'near-patient' testing technologies, not least due to concomitant advances currently being made in 'accessory' technological fields such as microfluidics, microengineering, photonics, increased signal detection sensitivity, and the miniaturization of essential components. The development and application of point-of-care/near-patient testing in the context of medical microbiological diagnosis (and to a lesser extent medical microbiological research), will provide immediate benefits both for the patient and the attending physician, allowing more rapid and better informed diagnoses and treatment schemes to be made. The net effect will be; i) to provide a better health service for patients, ii) to better understand disease epidemiology and the infection process, iii) to help reduce health-care costs, and iv) to limit the development and spread of infectious disease and antimicrobial resistance.
One thing is certain, research into 'new technologies' in medical microbiological research and diagnosis is continuing, financed by all types of business, including large industrial concerns, small / medium enterprises and university campuses, all of whom are working to push back the boundaries of our current scientific knowledge and technological innovation. This means that the 'next generation of new technologies' in the field of medical microbiological research and diagnosis promise to generate even greater benefits for physicians, patients and society as a whole .
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THE PETRI DISH
Much of modern microbiology is founded upon simple but powerful concepts that derive from the ability to grow pure strains of microorganisms in a controlled fashion. Before the development of axenic (microbiologically pure) culture in defined media, microbiology was not a coherent science. Microscopists such as Hooke and van Leeuwenhoek knew that there existed a complex and fascinating world on the micron-scale, but could perform very few actual experiments using their findings [1]. It was not until the development of microbial culture methods using "Petri" dish technology, (Petri being one of Robert Koch's students) that the role of microorganisms in disease could be experimentally verified [2] . It was the growth of microorganisms in a Petri dish filled with a nutrient gel matrix (most commonly agar), that allowed the segregation and manipulation of microorganisms into colony forming units (Robert Koch's description of a microbial community). This process of microbial culture was then refined via the use of selective agents, specific nutrients and indicators that allowed the characteristics of unusual colony phenotypes (including shape, smell, and colour) to be determined. This resulted in advances in the identification of particular bacterial species, eventually facilitating strain identification and microbial genetics [3] . The functionality of agar culture was further increased via the use of simple additional tools, such as metabolic indicator dyes and a velvet pad which was used to reproducibly replicate colonies (printing them by a simple stamping action) [4] .
So far so good. Billions of Petri dishes are used each year, having become the workhorses of basic and applied microbiology. Indeed, the use of microbial culture is still the "gold standard" method for the
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detection of many microorganisms, with developments in agar-based microbial culture having been primarily limited to a switch from glass to disposable plastic Petri dishes, as well as the subdivision of single plate culture into multiwell plate formats. However, the persistence of this technology is an indication of the value of such a simple tool. The advent of modern microbiological analysis techniques now means that the basic limitations of Petri dish-based culture are becoming increasingly apparent, particularly with respect to microbiological diagnosis and research. One of the major limitations associated with conventional agar protocols is that the Petri-dish culture process per se is difficult to automate with respect to high-throughput applications, there being particular problems related to the automation of specimen preparation, inoculation, incubation, and result interpretation. Moreover, though separate solutions for each of these issues exist, the result of integrating these systems into a functional robotic platform generates a system that is too large and/or inflexible for most microbiology laboratories [5] . Further, automated systems tend to be relatively expensive, limiting their application to centralized laboratories that perform a limited range of repetitive assays, meaning that small microbiology laboratories tend to be unable to automate at all. Finally, other limitations of conventional culture are: 1) agar-based microbiology creates a great deal of infectious waste, yet growth on agar usually involves the detection or assaying of visible colonies, a process that may be regarded as overkill in many situations, 2) agar may be an undesirable contaminant, or even inhibitory, in some downstream assay processes, 3) metabolic studies of bacteria have benefited greatly from continuous culture in a chemostat, but this is a situation effectively impossible to achieve on (or in) agar, 4) biofilms required for research purposes may be optimally formed on solid supports rather than on a gel, and 5) the vast majority of microorganisms have never been cultured in a Petri dish, and some may never be cultured due to their exacting growth requirements. All of these issues raise the question as to whether, in the long term, it is desirable to perform microbial culture in the laboratory at all. If yes, then the Petri dish is probably not the best format! If not, then what is the solution?
The aim of this chapter is to address the issues mentioned above by specifically discussing the advantages of porous supports in microbial culture, and how these supports have been engineered and/or modified to create useful culture formats with great potential for the future of microbiological diagnosis and research. Particularly relevant to the discussion are the recent advances made in materials and fabrication technology, advances that fall within the broad areas of microengineering, Lab-On-A-Chip (LOC) and nanotechnology [6] [7] [8] . The most promising of these advances involves the fabrication and application of "culture chips" based around an interesting ceramic, namely Porous Aluminium Oxide (PAO) [9] .
NANOPOROUS AND NANOFIBROUS MATERIALS
By definition, porous materials contain "open space" as well as "solid matter", with most of these materials possessing a porosity (ratio of the volume of open space to solid) of 0.2 to 0.95 [10] . Further, porous materials may be divided into 2 main types. "Open porous materials" possess pores connected to the exterior, whilst "closed porous materials" possess pores that are internal. Additionally, "penetrating pores", such as those in a membrane filter, go completely through a material, and pores with many twists and turns have a high tortuosity. For the microbiologist, the most interesting materials are usually open porous materials that possess penetrating pores.
The classification of pore sizes themselves can be rather confusing. In the IUPAC scheme a microporous material has a pore size less than 2 nm, a mesoporous material from 2 to 50 nm and a macroporous material has pores above 50 nm [10] . A rather more intuitive definition of a nanoporous material is a material containing a pore size from 1 to 100 nm with a porosity >0.4. The term microporous will be used in this chapter to describe porous materials with larger pore sizes, including most conventional (polycarbonate) sterilizing filters. Standard microscale filters, such as those used to sterilize liquids, are relevant but will not be described in detail as they are familiar to most microbiologists.
Porous materials have a high surface to area ratio, which is particularly relevant for some nanoporous materials. Oxides, metals, alumino-silicates, carbon and certain types of glass can all be nanoporous, and some commonly used materials are also nanoporous, such as the smaller (30 nm) polycarbonate filters. Additionally, a number of materials such as crystalline cellulose are nanofilamentous, with meshes created from layers of such materials being essentially nanoporous (Fig. 1) . Further, the study of nanoporous materials is a large and expanding field, with roles in particle separation, catalysis, energy generation, development as storage sensors, as well as applications as self-assembling materials.
BASIC MEMBRANE CULTIVATION SYSTEMS
It is worth briefly describing a few of the more basic systems utilized for the cultivation of microorganisms on microporous surfaces (in general, these are filters used for sterilization purposes), because they illustrate the usefulness of culture techniques in microbiological research and diagnosis, even if they are conceptually very basic. Further, this understanding will provide us with clues to the opportunities presented more sophisticated systems in the future. Screening Microbial Libraries on Nylon Membranes. The culture of microorganisms containing DNA libraries on porous membranes is a well established screening method in molecular biology [11] . The advantages of this system include the fact that bacterial colonies can be lysed in situ on the membrane (for example by washing and alkaline lysis treatment), the naked DNA being immobilized, which allows for further molecular analysis e.g. Southern blotting. In this case, the porous support comprises part of an integrated assay that combines microbial culture with molecular detection techniques.
Culture of Agarose Degrading Bacteria on Membranes. In some situations Streptomyces coelicolor and other bacteria are highly destructive to agar plates due to their production of agarase, an enzyme that can digest agarose. Such bacteria may be cultivated on a membrane that has been placed on an agar plate. The purpose of the intervening membrane is to separate the organism from the agar/nutrient matrix, thereby preserving the integrity of the plate and preventing the bacterium from becoming embedded in the agar. This simple method then allows the organism to be recovered for further microbiological analysis.
Counting Microorganisms on a Filter. A common practice in the water industry is to count microorganisms after filtration, e.g. for the enumeration of coliforms [12] . Essentially, the filter support acts to concentrate the sample, and provides advantages with respect to manual and automated colony imaging and counting. Filter membranes can also be colored for high contrast imaging or to reduce autofluorescence. Further, microbial staining with fluorogenic or colored dyes is possible, for example to assist in strain identification.
Subdivided Membranes.
A logical development to counting microorganisms on a filter is the Hydrophobic Grid Membrane (HPGM), where the filter is subdivided by a grid to create over a thousand
INTRODUCTION
Pathogenic microorganisms have affected civilisations throughout history, and many new disease-causing organisms have been discovered in recent decades. Examples include: rotavirus [1], Ebola virus [2] , Legionella pneumophila [3] , toxin-producing Staphylococcus aureus [4] , SARS [5] , pathogenic E. coli strains [6] , Borrelia burgdorferi [7] , HIV [8] , Helicobacter pylori [9] , Vibrio cholera [10] , Hantaviruses that cause pulmonary syndrome [11] , Nipah [12] , Hendra [13] , South American Arenaviruses that cause hemorrhagic fever (Junin, Machupo, Guanarito, Sabia, Chapare, Tacribe, Amapari) [14] [15] [16] , and novel strains of influenza [17, 18] . Moreover, new disease-causing organisms, that have yet to be catalogued as human pathogens, are still likely to be found in nature. Further, some pathogens can rapidly evolve, posing serious challenges to those tasked with preventing the outbreak and spread of infectious diseases. Finally, in recent years, an extra dimension to microbial disease epidemiology and pathogenesis has been the use of bioterrorism. For example, the anthrax attacks that occurred in the United States after 9/11 highlighted the potential dangers posed by the intentional use of biological threat agents against civilian and/or military targets (in fact, "bioterrorists" have tried since ancient times to deliberately spread diseases, but with varying degrees of success) [19] [20] [21] .
This e-Book chapter will address the utility of peptide-based probes and biosensors for detecting known pathogens in medical microbiological research and diagnosis, and is divided into the following sections:
1. The importance of developing highly sensitive, specific, fast and economical medical microbial biosensors for bio-threat preparedness and pandemic disease surveillance. 7. Predictions about the future appearance of rapid diagnostics and instrumentation in clinical environments.
The Need for Rapid Medical Microbial Biosensors
Many diseases show symptoms that do not correspond to a single infectious agent. For example, a variety of viral and bacterial pathogens may cause what are commonly called "flu-like" symptoms, i.e. fever, muscle aches and pains, fatigue, and headache. As a result, in the absence of (i) disease-specific findings (such as the characteristic rash of a poxvirus), or (ii) a known outbreak of a particular disease in the community, it may be very difficult to make an etiological assessment of an outbreak early enough to effectively treat many infected persons. Indeed, the earlier specific clinical testing is implemented, the sooner the diagnosis, the earlier treatment can begin, and the better the prognosis will be for infected individuals. This timing is critical for disease outbreaks because sick people will typically buy "over-thecounter" medications first, before going to their personal physicians or to a hospital emergency room when the over-the-counter drugs fail to relieve their symptoms. Doctors seeing such patients may initially make a diagnosis of an unknown viral illness, some type of influenza infection (especially if the outbreak occurs during the influenza season), gastroenteritis, or even encephalitis, with blood and urine samples subsequently being sent to a clinical laboratory for testing. However, it is not until physicians, or emergency room staff, have already seen several patients presenting with an identical "flu-like" illness, that they begin to recognize that something out of the ordinary (possibly a disease outbreak) may be occurring and decide to run additional diagnostic testing in order to pinpoint the pathogen responsible [22] . benefit of rapid medical microbial diagnosis in outbreaks of potentially fatal diseases is obvious, and the international community is currently implementing a variety of efforts to actually improve early diagnosis [23] [24] [25] [26] [27] [28] . For example, several organizations have created databases to monitor emerging outbreaks by collecting data on patient symptoms as they are treated in emergency rooms. Collectively these programs are referred to as "syndromic surveillance", and are aimed at reducing the time it takes for doctors to recognize major infectious disease outbreaks, and to determine whether the outbreaks "natural" in origin.
As an example of such a proactive "distributed environmental biosensor system", the Abstract: In medical microbiology, the identification of microorganisms in clinical specimens is a key step for successful therapy. In the last few years, new technologies have emerged for routine identification, among which matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS), a technology that appears very promising as it is currently becoming established in microbiological laboratories worldwide. MALDI-TOF MS allows the identification of microorganisms -bacteria as well as fungi -by so called intact-cell mass spectrometry, and the comparison of a sample's mass spectrum to reference mass spectra in a database. The key factors to the success of this technology are: i) the fact that a uniform sample preparation procedure is utilized for many different types of microorganisms, ii) the short time to a result, and 3) the comparatively low cost per analysis. Additionally, mass spectrometry based identification can be readily expanded to different microbiological fields, including food, industrial and veterinary microbiology.
In this chapter, the basic principles of MALDI-TOF MS are briefly described, followed by an introduction to intact-cell mass spectrometry of microorganisms and mass based identification. Further, limits of the technology are reviewed in the light of expected future developments. Finally, possible consequences of the broad introduction of MALDI-TOF MS based on microbial identification systems for practical and theoretical issues of medical microbiology are discussed.
Keywords: Mass Spectrometry, MALDI-TOF MS, Mass Spectra, Diagnostic Microbiology, Microbial Taxonomy, Spectral comparison.
THE IDENTIFICATION OF MICROORGANISMS IN CLINICAL SAMPLES
The identification of microorganisms is a crucial step in the diagnosis and therapy of human, animal, and plant diseases. Since the recognition of bacteria and fungi as etiologic agents of illnesses more than a century ago, elaborate methods have been developed for the selective isolation and identification of pathogens from all kinds of clinical and veterinary specimens. Most of the procedures used for the identification of microorganisms until recently depended on the isolation of a clonal sample and its culture on an array of multiple media containing particular substrates. The metabolisation of these substrates is then signalled by a colour change of an indicator, resulting in a pattern of positive and negative reactions. The metabolic pattern obtained is then used to identify the organism by comparing it to a database of reaction patterns of reference strains. Commercially available systems for the routine identification of clinical isolates have been automated to a high degree, allowing high throughput identification. However, despite the success and wide application of such systems, a number of disadvantages are becoming increasingly evident, including technical as well as conceptual problems. One category of disadvantages involves identification issues relating to isolates that are not able to metabolise most of the tested substrates and hence commonly are called "non-fermenting" bacteria. Further, automated identification using these systems requires the preparation of an ideally homogenous suspension, which is not always possible for particular bacteria, and practically impossible for filamentous fungi. Consequently, the latter organisms are not routinely identified using current commercially available identification systems.
The principle of biochemical identification has been developed in accordance to a species concept which in *Address correspondence to M. Welker: BioMérieux -R&D Microbiology, 3 route de Port Michaud, La Balme les Grottes, 38390, France; Email: martin.welker@biomerieux.com turn has been largely based on metabolic patterns. Hence, this biochemical identification procedure is prone to circular reasoning and is considered problematic in the light of new available data and techniques. Since the advent of the genomic era, a number of species concepts for prokaryotes have been postulated, discussed, and rejected, but without agreement on a broadly acceptable concept [1] [2] [3] . Consequently, bacterial species are still defined by conventions and parameters that are considered as objective phylogenetic markers, i.e., the nucleotide sequence of the 16S rRNA gene and DNA-DNA-hybridisation values between clones [4, 5] . However, both of these markers possess flaws as they are either not discriminative enough, or are impractical in times when the sequencing of a complete bacterial genome can be performed relatively rapidly. Further, the concept of a "tree of life" (comprising a bifurcating phylogeny) has been challenged by the analyses of complete genomes of large numbers of bacterial strains [6] , with genomic studies revealing that the number of shared genes between clones of the same species (as defined by taxonomists) -can be as low as 40% [7] . In this light, the identification of bacterial species by metabolic patterns is prone to errors, especially if non-typical clones are analysed. These non-typical clones may lack or may have acquired genes coding for fermentative enzymes that generate a deviation from the "conventional" metabolic pattern observed in typical clones of the same species. Therefore, classical clinical microbiology will likely face various paradigm shifts in the near future that will also profoundly affect the way in which routine microbiological diagnosis is performed. These shifts will require the 
PRINCIPLES OF MALDI-TOF MS
MALDI-TOF MS is a recently developed technology, with the first fundamental studies being published in the mid-1980s [8] . The key publications which eventually lead to a commercially available instrument were published in 1988 independently by two groups, and were later honoured by a Nobel prize bestowed on one of the authors [9, 10] . Essentially, two main features of MALDI-TOF MS have triggered the rapid and profound success of this new technique. Firstly, it became possible to detect molecules as non-fragmented ions with molecular masses exceeding 100,000 Da for the first time. Secondly, biological samples could be analysed after a very simple sample preparation without the need for a preceding separation step, for example, chromatography. Both of these features were exploited in what was soon called 'intact cell mass spectrometry' (IC-MS), the analysis of whole microbial cells. In fact however, the analysed bacterial cells cannot be considered as intact, as the sample preparation procedure causes substantial cell wall disintegration, meaning that the term 'whole cell mass spectrometry' would be more appropriate. However, because the term IC-MS has been used in many previously published studies, this term will be used in this chapter.
Initial studies using IC-MS of bacteria showed that the mass spectral pattern of different species differ substantially [11, 12] . Further, in these early studies, the potential of the use of IC-MS for bacterial identification was discussed but it required a number of further studies in the following years to prove that this could indeed be achieved. Unfortunately, a detailed description of MALDI-TOF MS cannot be given here, and the reader is advised to consult analytical chemistry textbooks for further information. Nonetheless, the basic principles required to understand the concept of mass-based microbial identification are outlined in this chapter (Fig. 2) . During mass spectrometry-based analysis, the molecules to be detected (the analytes) are embedded in crystals of a matrix compound. The matrix compound is required for two reasons. Firstly, the matrix is able to absorb photonic energy from a laser beam. Secondly, the matrix facilitates the transfer of electrical charge from matrix molecules to analyte molecules. The matrix compound should ideally be a small molecular weight compound in order to avoid interference with analyte molecules, which usually possess a much higher molecular mass. Commonly used matrix compounds include primarily small aromatic organic acids, as these possess high energy absorbance coefficients at the wavelengths of commonly used lasers, and can act as both proton donors and proton acceptors. The most common matrix compounds used are 2,5-dihydroxybenzoic acid, α-cyanohydroxy cinnamic acid, and sinapic acid, with the co-crystallisation of matrix and analyte molecules being generally achieved by simple room-temperature evaporation of a matrix solvent/analyte mix directly on the sample plate. For analysis, a laser beam is focused at the matrix/analyte crystals and fired in pulses of a few hundred nanoseconds. The absorbed photonic energy causes the desorption of matrix and analyte molecules (under the high-vacuum conditions present within the instrument (<10 -6 mbar)), into the gas phase, whereupon charge transfer occurs between the photonically excited matrix and the analyte molecules [13] . All ions produced are then accelerated in an electromagnetic field that is built up between the sample plate and a grid or ring electrode placed a distance of a few millimetres apart. In modern instruments, the electromagnetic field is engaged with a short delay of 0.1-1 microseconds after the laser pulse has hit the sample so that either positively or negatively charged
THE CONCEPT OF (META-) METABOLOMICS
Metabolomics is the analysis of the metabolite profile of cells from any origin. If the analysis is applied to a complex sample, such as whole microbial communities, then, the term (meta-) metabolomics is often used. The origin of the metabolic molecules that comprise the "metabolome" can be either endogenous e.g. the products of biosynthesis and catabolism, or exogenous e.g. nutrients, pharmaceutical compounds or degradation products. Therefore, the study of the chemical diversity and range of concentrations of both the intra-and extracellular (meta-) metabolomes are essential if a complete understanding of a biological system is to be obtained. Further, though analysis of cellular metabolites allows inferences to be made regarding the biochemical functioning of organisms [1], this information is by no means comprehensive unless it is complemented by accompanying studies investigating the different functional levels of a biological system, i.e. the (meta-) genome, the (meta-) transcriptome and the (meta-) proteome [2] [3] [4] [5] (Fig. 1) . Additionally, when studying the diversity and range of concentrations of intra-and extracellular metabolic molecules, it should be remembered that (meta-) metabolomics only provides a blueprint of metabolic reactions (and the possible role of each reaction) based upon a particular environment [6] [7] [8] , i.e. not every metabolite is produced under all environmental conditions. Indeed, the metabolic molecules obtained from microbial specimens and communities may be formed only under specific conditions, and usually in response to external environmental stimuli e.g. aerobic versus anaerobic culture, etc. [9, 10] . Finally, slight variations in the techniques used for sample preparation, metabolite measurement/quantification and data analyses may be observed between different laboratories [11] . However, metabolites (such as substrates, intermediates, products and cofactors) are essentially the "fingerprints" of combined enzyme and transporter system activity within cells [12, 13] . Therefore, the identification and quantification of metabolites within a biological system is especially interesting for biomedical research and diagnosis, as it facilitates the identification and fingerprinting of biochemical perturbations caused by, for example, disease, drugs and toxins [14, 15] . Fig. (1) . Metagenomics applications and the study of the human microbiome. (A) The microbial colonization of skin, genitourinary system, oral-respiratory-and gastrointestinal-tracts begins immediately at birth. It is estimated that a human adult body contains approximately 100 trillion microbial cells that outnumber the host's own cells by approximately ten to one [101] . Currently, the study of host microbial diversity utilizes high-throughput technologies that aim to identify stable phylogenetic markers (metagenomic and rRNA-based techniques) rather than methods that rely in growing organisms in pure cultures. (B) In order to fully understand the functioning of the complete microbial community, a (meta-) genomic, transcriptomic, proteomic and metabolomics approach (systems metagenomics) is required. (C) One of the main goals of human-microbial systems metagenomics is to determine whether a core microbiome (i.e. a set of microbial genes present in a given habitat in all or the vast majority of humans) exists, how variable this core microbiome is, and to understand if changes in the human microbiome can be correlated with human health (either beneficial, neutral or adversarial). Variation in the human microbiome could result from a combination of factors related to, i) the host (immune response, nutritional status etc), ii) the surrounding biosphere (nosocomial, rural, urban environments etc), and iii) features linked to the populations of microorganisms (gene content, number of species present, functional capabilities).
Guazzaroni et al.
Before describing the state-of-the-art of medical microbial (meta-) metabolomics, a number of definitions need to be introduced [16] . "Metabolites" are the intrinsically complex small-to-medium sized molecules (Mr lower than 1000 Da) that direct cell differentiation and maintenance within the cell cycle. The complete set of metabolites in a biological system is named the "metabolome", while the actual measurement of metabolites may have different definitions, -"metabolomics" and "metabonomics" are used to define the static and dynamic identification and quantification of the metabolic space (i.e. the total population of metabolites), respectively. Further, if quantitative analysis is restricted to the analysis of a limited set of metabolites within a selected biochemical pathway, then, the most appropriate term to use is "metabolic profiling" [1, 17] . In this context, the term "metabolic fingerprint" is used to classify and discriminate between the global intra-and extracellular metabolomic patterns generated by samples in response to specific external stimuli [18, 19] . If the analysis is restricted to excreted metabolites that are generated in a cell culture as a reflection of metabolite excretion or uptake, the term "metabolic footprinting" is used [20] . Also, at this stage, the study of the metabolome should be distinguished from the analysis of "metabolic capabilities" [21] , which provides a complete analysis of all cell constituents including the genomic, proteomic and biochemical fingerprints of communities, and yields information regarding the taxonomy, functions, physiology, and abundance of community members. Further, the measurement of "metabolic activity" (i.e. total sample enzyme activity) may be combined with the analysis of metabolites, in order to determine the level of activity of specific microbial populations [12, 22, 23] .
With respect to microbiological research and diagnosis, metabolomic profiling of biochemical reaction products, may be used to elucidate metabolic pathways and metabolic bottlenecks that may be useful for antimicrobial therapy, and in the context of microbial communities, may useful in tracking the complex metabolic interactions between microorganisms in response to, for example, quorum sensing signals. Further, metabolomics may be used to identify potential metabolic differences between microbial and mammalian cells [1] , possibly useful in the development of novel diagnostic testing technologies.
THE HISTORY OF -OMICS AND (META-) METABOLOMICS
The first -omics term to be introduced was "genome" [2] , followed in 1988 by the term "genomics" [2] . One year later, the concept of "meta-genomics" come into use, defined as the application of modern genomics techniques to the study of communities of microbial organisms directly in their natural environments, bypassing the need for isolation and lab cultivation of individual species [2] . This field actually had its roots in the cultureindependent retrieval of 16S rRNA genes, pioneered by Pace and colleagues more than two decades ago [24] . Since then, (meta-) genomics has revolutionized microbiology by shifting the research focus away from single microbial isolates towards the estimated 99% of microbial species that cannot currently be cultivated [2] . While a genome represents the full genetic (DNA) complement of a single organism, (meta-) genomes represent the DNA of an entire community of organisms, and there are now thousands of genomes, including (meta-) genomes, available for study (see the Genomes Online Database at http://www.genomesonline.org) [25] . For example, in 2007, the Global Ocean Survey published scientific analyses of 41 (meta-) genomes [26] , and as of October 2008, the submission of user-generated (meta-) genomes to the public MG-RAST annotation server surpassed 1300 [27] . We have now entered an era of so-called '(mega-) sequencing projects' that now include, as examples, the Genomic Encyclopedia of Bacteria and Archaea (GEBA) project Proteomics (the study of whole cell protein production and function), followed genomics somewhat later in 1997, with proteomics research rapidly growing until the number of proteomics publications surpassed the number of genomics publications in 2009, now plateauing at approximately 3000 publications a year [2] . Although, protein isolation techniques have been traditionally applied to pure cultures of microorganisms, advances in "high-throughput" proteomics provided new tools for obtaining an integrated insight into the functioning of complex biological samples. In this context, the term (meta-) proteogenomics or (meta-) proteomics was introduced in 2004 to study the complex mixtures of proteins from an environmental sample [28] [29] [30] . Techniques such as 2-dimensional electrophoresis (2-DE) coupled to high-throughput mass spectrometry-based analytical platforms can now be used to separate and identify hundreds of proteins from
INTRODUCTION
Everyone who has ever cultured microorganisms knows that certain bacterial species produce odours during growth, some of which are species-specific, and belong to several clinically important bacteria. This odour may be a characteristic sign of the presence of a particular bacterial species, a fact that can be important in the field of bacterial diagnostics. An experienced person may be able to determine which microorganism is present within a specimen, just by carefully sniffing a specimen that has been cultured. A few examples of these bacterial species and the type of smell they produce are shown in Table 1 , and the relationship between disease and aroma producing microorganisms can be found in reference [1] .
The use of smell as a diagnostic aid in the detection of infectious diseases has been known since ancient times. For example, Hippocrates mentioned the diagnostic value of smell in his work called "Aphorisms" written in 400 BC [2] , and wrote: in Section IV:81. 
Bacterial species Odour
Clostridium difficile Horse-like These quotes show that the olfactory diagnosis of infectious diseases has a longstanding history, though the possibility of using odour to identify a particular bacterial species was only re-discovered in 1922, when Omelianski described the aroma producing capacities of several species of microorganisms [3] . In the current age of modern immunological and molecular diagnostics, the art of olfactory diagnosis is slowly disappearing. However, given the simplicity and ease of olfactory diagnostics, this field may still provide an attractive means for the laboratory-based identification of infections in real time. Ultimately, this will require the development of specific instrumentation that is not vulnerable to bias or to inter-individual quality variation. This is where modern electronics and software play an important role. Fig. (1) . Comparison of the steps required to detect an odour using either a biological or an electronic nose.
Haemophilus
Burnt Caramel
Streptococcus milleri Butterscotch
Pseudomonas aeruginosa Almond
Streptomyces spp Earth
Eikenella corrodens Bleach
Streptococcus constellatus Caramel
The concept of an electronic nose originated in the 70s of the previous century. Up to then, analytical chemistry had been pre-occupied with developing highly specific sensors and methods aimed at identifying unique substances. However the availability of personal computing made it possible to apply pattern recognition techniques to complex data measurements, including analytical chemistry measurements. The general idea was to develop a broadly responsive sensor system and use pattern recognition systems to match "unknown response" patterns to previously "observed response" patterns, thereby identifying the specific odours present within (complex) mixtures. In fact, this is analogous to how we humans smell complex mixtures of unknown substances that contain a characteristic odour, hence the name "electronic nose". The principles underlying this approach are illustrated in Fig. 1 .
An important consequence of this electronic nose concept is that a substance, or mixtures of substances, can only be recognized after a calibration phase. That is, in order to match a complex pattern of odours, it is first necessary to possess a database that defines one or more of the odour patterns. This means that all electronic noses currently available are reliant on the use of a searchable (digital) database where characteristic odour signal patterns obtained from previous measurements are stored. In this way novel odour signal patterns can be matched with an existing odour pattern result via comparative pattern recognition analysis, ultimately leading to pattern (and hence odour) identification.
At this moment in time, the electronic nose is most often commercially used in the food industry and in environmental monitoring. These are relatively simple applications as their main purpose is the detection of "abnormal" situations i.e. the electronic nose continuously monitors a process line or environment and detects anything deviating from the normal situation. This deviation then acts as a trigger to start looking for the reason of the deviation in odour. These kinds of applications are very useful in situations where every deviation from a normal situation is cause for action, especially when the "abnormal" situation rarely occurs.
Currently, there is no known device or application that utilizes electronic nose technology present within medical microbiology laboratories, though there has been research into the possible medical diagnostic applications of electronic nose technology, with in general, promising results [4] [5] [6] [7] . In this chapter, the authors explain why these devices are not currently in use and how we think these problems can be solved.
CURRENT ELECTRONIC NOSE TECHNOLOGIES
Every sample preparation method that produces volatiles is usable in theory for "electronic nose detection", including methods that involve the heating, burning or chemical treatment of a sample, though these methods will of course destroy the actual sample. Also, in the literature, GC-MS (gas chromatographymass spectrometry) systems are sometimes described as electronic nose devices. However, though gas chromatography and mass spectrometry can be used to separate, quantify and identify volatile chemicals, they do not indicate whether the compound is associated with an odour or not. In fact, an odour is mostly a "blend" of compounds that combine to create a specific odour. This blend is actually separated by GC-MS systems analysis, thereby destroying the specific odour itself and are therefore "technically speaking" not genuine electronic noses.
In effect the basic sensor technologies most commonly incorporated into modern electronic nose (e-nose) technologies are:
1. Quartz Microbalance (QMB)
Conducting polymers (CPs)
3. Semi-conducting metal oxides (MOS)
4. Miscellaneous 1. Quartz Microbalance (QMB) is a quartz crystal with a chemically active surface, usually a polymer. When gas molecules adsorb to the surface, the mass changes and the resonance frequency of the crystal shifts. These minute shifts are then measured using high frequency electronics (which are complex and expensive). However, small temperature variations in the environment may also generate similar frequency shifts requiring the maintenance of strict environmentally controlled temperature conditions. A variation of a QMB sensor is a SAW (surface acoustic wave) sensor, which is based upon changes in an acoustic wave applied to the surface. Changes in surface composition change the path of the wave and hence the wave's characteristics.
2. Conducting Polymers (CPs) are polymers which have been 'loaded' with graphite. The graphite provides an electrical resistance path that can be easily measured. When gas molecules associate with the polymer, it swells, breaking contact points between the graphite particles and thus changing the resistance. Similar to QMB sensors, temperature and/or humidity changes will result in expansion/contraction of the sensor and lead to changes in resistance profiles, again requiring the use of strictly controlled environmental temperature conditions. Although the number of possible polymer variants is enormous (and thus the number of sensor array variants), polymers tend to be rather unstable. Strong oxidizers such as chlorine and ozone can fairly easily disrupt these polymers and thereby destroy the sensor.
3. Metal-Oxide (MOS) are sensors based on the principle that certain metal-oxides behave as semiconductors at high temperatures. Sensors based on this principle are designed to bring together a heating element and a sensor element (usually a sintered metal-oxide with or without catalyst). Both elements are separated by a very thin isolating membrane. Redox-reactions occurring at the sensor surface
INTRODUCTION
Despite the progress recorded to date, infectious diseases are still considered major causes of disability and death [1]. The problem is most intense in those countries that cannot afford to allocate the financial resources required for the application of effective control measures. Further, this situation applies not only to humans, but also to animals, which are often the source of transmission of pathogens to humans either directly or via the food chain. The accompanying social and financial impact of these infectious diseases has led to a focus on the development of new diagnostic tests with improved characteristics. These new diagnostics tests may vary in their methodology, dependant on the target application, but in general demonstrate high reproducibility, sensitivity and specificity, and a more rapid 'time-to-diagnosis'. Further, since the 1980s, molecular biology research has led to some successes in meeting the demands for such tests. PCR, PCR-RFLP, Real Time PCR, DNA sequencing, and DNA strip (dipstick) technologies have considerably improved the speed and accuracy of microbial detection, having facilitated the development of applications that are impossible using traditional means of diagnosis. However, the reliable application of these new methodologies requires highly-specialised personnel, dedicated equipment and distinct laboratory specimen preparation areas. This latter requirement is a consequence of avoiding "carry-over" (i.e. the accidental contamination of test samples by amplicons generated during previous PCR reactions), a consequence of the large numbers of amplicons generated during PCR thermocycling. Carry-over can easily lead to false positive results even in the presence of minute quantities of contaminating DNA. These disadvantages do not however apply to the use of "nanodiagnsotsics".
Recent advances in nanotechnology mean that nanoparticles can now be applied to the study of biological *Address correspondence to J. Ikonomopoulos: Faculty of Animal Science, Laboratory of Anatomy-Physiology, Agricultural University of Athens, 75, Iera Odos st., 11855 Athens, Greece; Tel: 00302105294383; E-mail: ikonomop@aua.gr processes at dimensions comparable to that of the atom. Further, nanoparticles permit a more efficient interaction between biological molecules due to the one-on-one interactions between the target molecule and the signal generating moieties. Nanotechnologies are becoming available with the ability to detect increasingly smaller amounts of biological materials, without the need for target amplification. Indeed, due to their unique chemical, optical and electronic properties, nanoscale probes are suitable for the detailed analysis of molecule-size receptors, pores, and other components of living cells. Further, nanoparticles can be conjugated to oligonucleotides, antibodies, and peptides, allowing multi-labeling (and multi-target) diagnostic applications to be designed that identify specific genetic and/or immunological pathogen "footprints". Most importantly, nanotechnology currently offers the means for the creation of novel technology platforms that are specifically designed for the diagnostic investigation of infectious diseases, including point-of-care applications with no reliance on specialized personnel or expensive equipment.
PROPERTIES OF NANO-PARTICLES
As previously mentioned, advances in the field of molecular biology have gradually become a major cornerstone of research in the "Life Sciences", all within a period of less than 20 years. The intradisciplinary collaboration that this integration required was supported by a foundation of basic biology that was commonly available to all the interacting scientists. Unfortunately however, this common background does not apply to nanotechnology. In the case of nanotechnology, interacting scientists from the fields of physics, chemistry, molecular biology and microbiology all have to understand the many divergent concepts that are derived from these distinct fields. With this in mind, in this chapter, the authors aim to provide a concise description of the basic characteristics of nanoparticles in a rather simplistic manner in order to facilitate the understanding of their potential use in pathogen detection. Currently, biological imaging techniques in many applications rely heavily on the use of fluorescent proteins and organic dyes as markers. However, these markers suffer from several major disadvantages, such as low probe brightness, poor photostability, and oxygen sensitivity [2] . This means that there is often a need for signal amplification, which limits their usefulness in many in vitro and in vivo applications. Nanoparticles offer an exciting technological advancement that can eliminate and overcome the above problems, offering state of the art detection solutions for both in vitro and in vivo applications.
The term nanoparticle is commonly used to describe particles with dimensions less than 100 nm, as opposed to 'bulk material', which is expected to demonstrate a specific physical behavior regardless of size. In fact, nanoparticles may actually exhibit different properties dependant on their size and on the percentage of atoms located at their surface (the surface area of nanoparticles being significantly larger than that of bulk materials). Consequently, nanoparticles demonstrate an unexpected behavior, otherwise referred to as the 'quantum effect', which influences their optical, electrical, chemical and physical characteristics. For example, their high surface area to volume ratio gives them unique properties when used in dispersants, as they possess a very strong tendency to diffuse, avoiding deposition, or floating. In terms of their optical characteristics, an interesting feature of semiconductor nanoparticles is that the minimum amount of energy required for the release of an outer electron from its nucleus (bandgap) is size-dependent, which translates into a color shift from red to blue as the size of the particles decrease [3] . Further, the variable optical characteristics of these nanoparticles (compared to bulk materials) also extends to their electrical properties, allowing the construction of semiconductors whose conductivity can be accurately calibrated within a range of energies by using particles of specific sizes. Finally, colloidal particles can act as robust, broadly tunable nano-emitters that can be excited by a single light source, providing distinct advantages over current fluorescent markers (including organic dyes and fluorescent proteins).
There are a number of metal or polymer nanoparticle materials currently available, whose use is dependant on the properties required in a particular application. In the last few years, nanodiagnostic applications have tended to focus on colloidal gold and cadmium selenide quantum dots, which seem to be very promising materials in terms of pathogen detection.
Colloidal gold nanoparticles (AuNPs) range in size from 3-100 nm, they are stable, uniform and monodispersed particles that can be easily produced by various chemical processes, among which the reduction of chloroauric acid by citrate. Metal nanoparticles (or NPs) exhibit strong size-dependent optical resonance, tunable for emission in the near-infrared (NIR) part of the spectrum, which is generally known as Surface Plasmon Resonance (SPR) [4] . This resonance is pronounced in noble metal NPs because of the collective oscillations of conduction band electrons. SPR is especially interesting with reference to Au (and also silver (Ag)) NPs. When metal NPs are photo-activated, the plasmon couples with the excitation light to produce a large enhancement of the electromagnetic (EM) field. Interactions between the incident light and the oscillating electric fields result in the scattering and absorption of light. The enormous enhancement of the local EM field make metal NPs attractive in applications from optical devices to bioanalyses and bioimaging, and can be exploited to generate a color change (visual detection), or heat (for the construction of biosensors) [5] .
AuNPs are negatively charged and are very sensitive to changes in the "dielectric constant" of a solution [6] . This sensitive change is significant in terms of their potential application in diagnostics, since (for typical citrate stabilized particles) the addition of NaCl neutralizes the surface charge and can cause a decrease in inter-particle distance. This decrease can be utilized to selectively deposit the AuNPs eventually resulting in a change of color detectable by visual observation [6] . The same result can be achieved by linkage of two or more functionalized (i.e. chemically modified for conjugation) AuNPs to a target molecule of DNA, which results in particle aggregation as the distance between the particles is decreased.
The properties of AuNPs have been utilized to construct several different types of detection mechanisms, including visual observation of a color change or measurement of optical absorption. In all cases, the basic idea is that in solution, monodispersed AuNPs appear red and exhibit a relatively narrow surface plasmon absorption band centered at around 520 nm in the UV-visible spectrum. In contrast, a solution containing aggregated AuNPs appears purple in color corresponding to a characteristic red shift in the surface plasmon resonance of the particles from 520 nm to 574 nm. Further, colloidal silver and gold particles offer some other unique features, they do not undergo any photodecomposition, which is a common problem encountered when using fluorescent dyes. Secondly, they are not toxic, in sharp contrast to the potential toxicity of semiconductor QDs (see later). Thirdly, they are reasonably stable and can be stored in a dry state. Lastly, there exists a capability to shift their 'Surface Plasmon Resonance' (SPR), in a controlled fashion, to the spectral region best suited for optical bioimaging and biosensing applications. Therefore the use of these materials as nanoparticle biosensors relies on signalling via a shift in the absorption of different wavelengths of light that can be measured mechanically, or be detected visually by a resulting change in color.
Nanometer-scale semiconductor crystallites, better known as Quantum Dots (QDs), are semiconductor crystals with physical dimensions smaller than the exciton Bohr radius [7] . A typical exciton Bohr radius for QDs is of a few nanometers, though this property does depend on the material used to construct the nanoparticles. Indeed, those metal and semiconductor nanoparticles in the size range of 2-6 nm are currently of considerable interest due to their dimensional similarities with biological macromolecules i.e. nucleic acids and proteins. Colloidal semiconductor nanocrystals can be produced using various semiconductors including Cadmium Selenide (CdSe), Cadmium Sulfide (CdS), indium arsenide (InAs), indium phosphide (InP).and lead sulfide (PbS). These materials exhibit size-dependent fluorescenceemission wavelengths (a defining feature of QDs), a very significant property in terms of their potential use as biosensors. When a photon of visible light hits such a semiconductor, some of their electrons are excited into higher energy states. When these electrons return to their ground state, a photon is emitted with a frequency that is characteristic of the semiconductor material. The ability of QDs to release photons (in effect their photoluminescence), can actually be improved using specific types of "inorganic shells". In more detail, the surface of QDs contain non-radiative recombination sites. When an electron returns to its valence state from the conduction band, it usually emits the excess energy in the form of heat instead of photons. In other words the presence of search sites causes a loss of optical signal, a process that can be avoided by blocking the relevant sites using inorganic shells (sites are "passivated") [8] . When blocked, the excited electrons will release photons upon their return to their valence band. In effect, the shell makes QDs brighter and more sensitive to change as the QDs then require less energy to be excited (e.g. adding a ZnS shell around a CdSe core [9] ). Another very widely used coating material for QDs is silica [10] . This high-
INTRODUCTION
Recent developments in rapid molecular testing methods have greatly enhanced the ability of diagnostic and research laboratories to identify and characterize microbial pathogens, with nucleic acid amplification strategies and advances in amplicon detection having been key aspects in the progress of molecular microbiology-based detection. Indeed, sophisticated new combinations of amplification/detection technologies are resulting in an increasing number of applications with respect to laboratory testing for infectious diseases. The development of technologies possessing rapid and sensitive detection capabilities, and increased throughput, have become crucial in the global response to an increasing number of threats posed by emerging and re-emerging microorganisms, especially viruses.
Nucleic acid amplification technologies are the leading methods used to detect and analyze the small quantities of nucleic acids found in microorganisms. Of these, the Polymerase Chain Reaction (PCR) is the most widely used method for DNA amplification for the detection/identification of infectious diseases, genetic disorders and other research purposes. Unfortunately however, despite the high magnitude of amplification, these PCR based methods require either high precision instrumentation for efficient and accurate amplification of DNA, and/or elaborate methods for the detection of any successfully amplified products. In addition, these methods are often cumbersome to adapt for routine clinical use in peripheral health care settings and private clinics. Further, traditional PCR amplification technology possesses several intrinsic disadvantages, including: a requirement for thermal cycling; careful optimization to yield sufficient specificity and high amplification efficiency; separate methods to detect amplified products (e.g. gel electrophoresis); and a major reliance on diagnostic PCR assays that reported qualitative ('yes/no' format), rather than quantitative results. Finally, the time required to achieve a result using traditional PCR technology is relatively long. More recently however, so-called "real-time"-based assays have been The development of real-time PCR (including the ability to accurately quantify nucleic acids) has brought PCR-based nucleic acid detection technology out of the pure research laboratory and into the diagnostic laboratory, with real-time PCR amplification technology combining traditional PCR-based amplification with fluorescently labeled, microorganism specific, probes. These fluorescent probes are able to detect amplified DNA during the amplification reaction. This fluorescent chemistry coupled with advances in optical detection now means that real-time PCR is more sensitive than conventional gel based PCR [1]. Over the past two years, several real-time PCR assays have been developed to address the need for reliable detection systems for the early detection, as well as quantification, of virus load in the acute phase of illness. In addition, real-time PCR automates the laborious process of amplification by quantifying reaction products for each sample in every cycle. Data analysis, including standard curve generation and copy number calculation, is performed automatically. Real-time PCR has enhanced wider acceptance of PCR due to its improved rapidity, sensitivity, reproducibility and the reduced risk of carry-over contamination.
More recently, several investigators have reported the development of fully automated real-time PCR assays for the detection of viruses in acute-phase serum samples. Unfortunately however, all of these PCRbased nucleic acid amplification methodologies possess several intrinsic disadvantages, and require high precision instrumentation for amplification and/or detection of amplified products. Real-time PCR requires an instrumentation platform that consists of a thermal cycler, computer, optics for fluorescence excitation and emission collection, as well as data acquisition and analysis software. Only a few laboratories with good financial resources can afford to purchase such high precision instrumentation. Finally, "trust" issues associated with the replacement of "gold standard" microbiological detection methodologies by new technological screening systems, currently means that it is widely accepted that test results should be confirmed by more than one type of assay technology.
Novel developments in the in vivo synthesis of DNA have provided a basis for the development of technologies that allow the amplification of DNA under isothermal conditions, without the need for a thermocycling apparatus (a requirement of PCR-based amplification technology). The recent identification of various DNA polymerase accessory proteins has enabled the development of new in vitro isothermal DNA amplification methods, which may mimic the mechanisms found in vivo. In fact, there are currently several types of isothermal nucleic acid amplification methodologies described, including: i) transcription mediated amplification [2] ; ii) nucleic acid sequence-based amplification [3] ; iii) signal mediated amplification of RNA technology [4] ; iv) strand displacement amplification [5] ; v) rolling circle amplification [6] ; vi) isothermal multiple displacement amplification [7] ; vii) helicase-dependent amplification single primer isothermal amplification [8] ; vii) circular helicase-dependent amplification [9] ; and viii) loop-mediated isothermal amplification of DNA (as described in this chapter). Indeed, LAMP technology has now been developed into commercially available test kits, some of which have been adopted as officially recommended methods for the routine identification and surveillance of pathogens (in Japan) [10] . This new generation of simple, rapid and cost effective gene amplification technologies possess all of the characteristics required for: i) the routine detection of microbial pathogens; and ii) monitoring of the re-emergence and resurgence of large scale microbiological epidemics. In this chapter, the authors describe the potential application of Loop-Mediated Isothermal Amplification (LAMP), a technology that is gaining popularity among researchers and diagnosticians, due to its simple operation, rapid time-to-diagnosis, and easy detection. The chapter describes the usefulness of this novel gene amplification technology in microbiological diagnosis and medical microbiological research.
LOOP-MEDIATED ISOTHERMAL AMPLIFICATION TECHNOLOGY (LAMP)
The principal of LAMP is based on nucleic acid amplification via an autocyclic strand displacement reaction, which is performed at a constant temperature of approximately 63°C. The method employs a DNA polymerase and a set of 6 specially designed primers that recognize a total of 8 distinct sequences on the target DNA. The process itself comprises both non-cyclic and cyclic steps, which will be explained later in this chapter. Further, the amplification and detection of a specific gene can be completed in a single step, using a mixture of target sample, specifically designed primers, a DNA polymerase possessing strand displacement activity, and relevant substrates [1] . Importantly, the high amplification efficiency of the LAMP reaction yields a large quantity of by-product, pyrophosphate ion, leading to the formation of a white precipitate of magnesium pyrophosphate in the LAMP reaction mix. The production of this precipitate leads to a subsequent increase in the turbidity of the reaction mix, with the turbidity of the precipitate being correlated to the amount of DNA synthesized. This means that the real-time monitoring of LAMP reactions can be performed using real-time measurement of turbidity formation [11] . In fact, the whole LAMP protocol can be performed at a constant temperature by simply incubating the reagents in an incubator, water bath, heating block, or any other heat source that can provide a constant temperature of 60-65°C for 30 minutes. Being an isothermal-based amplification methodology, LAMP does not require a sophisticated thermal cycling apparatus, and as previously mentioned, the detection of specific amplification products can be determined without the use of sophisticated detection devices. This means that LAMP has the potential to be developed into a cost effective, point of care testing technology. Finally, with specific respect to medical microbiological diagnosis, LAMP technology has been used for the detection of a wide range of bacterial, viral, fungal and parasitic diseases of humans, animals and plants (see section 'Applications of LAMP in Medical Diagnostics below').
THE DESIGN OF LAMP PRIMERS
The design of highly sensitive and specific primer sets are crucial when developing a LAMP amplification protocol. To help in this process, the correct design of LAMP primers may be accomplished using the software program "Primer Explore", a LAMP primer design and support software program available at the Net laboratory, Japan: http://venus.netlaboratory.com. This program takes into account primer base composition, GC content, and the formation of secondary structure. The total primer set required for LAMP amplification utilizes a mix of 6 primers (3 primer pairs), which comprise 2 "outer", 2 "internal" and 2 "loop" primers that recognize 8 specific nucleic acid sequences present within the target sequence (Fig. 1) . The 2 outer primers comprise a forward outer primer (F3) and a backward outer primer (B3), which play a role in strand displacement during the non-cyclic step only. The 2 internal primers FIP and BIP (forward and backward internal primers), possess both sense and antisense sequences in such a way that they have the ability to form "loops" (FIP contains sequences F1C and F2, whilst BIP contains sequences B1 and B2C). 
INTRODUCTION
Physicians depend on effective antimicrobial therapy in order to successfully treat illnesses caused by microorganisms, especially infections caused by bacteria. However, the clinical symptoms of many infectious diseases (such as meningitis, encephalitis, pneumonia, otitis, and tonsillitis) can be quite similar, regardless of whether the etiological agent involved is bacterial, fungal or viral in origin. Further, there is a current lack of reliable and rapid diagnostic microbiological technologies that are able to distinguish between bacterial, fungal and viral infections, meaning that clinicians often empirically prescribe so-called "broad spectrum" antibiotics (just to be on the safe side), in order to eliminate the risk of a severe and possibly life-threatening bacterial infection. However, the antibiotic treatment of fungal and viral illnesses, or non-infective causes of inflammation, is ineffective, and contributes to the development of antibiotic resistance in commensal bacteria, as well as toxicity and allergic reactions in the host, ultimately leading to increased patient morbidity and increased medical costs [1, 2].
In fact, antibiotic resistance has been called one of the world's most pressing public health problems. For example, society pays for the costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) in increased tax or insurance charges, which have been estimated to be between $17 billion and $30 billion per year in the USA, discounting the costs of litigation. In the UK, MRSA has been estimated to cause an annual loss of between £3 billion and £11 billion to the economy [3, 56] . The correct use of antibiotics would allow a decrease, or even reverse, in the spread of resistance, and increase the costeffectiveness of healthcare. One major factor adding to the unnecessary use of antibiotics is a lack of rapid and accurate diagnostic tests. VOLUME 1), that included ways to limit the excessive and uncontrolled use of antimicrobial agents. In this strategy, the development of rapid and reliable diagnostic tests was included as an essential prerequisite for the prudent prescription of antibiotics.
Several methods have so far been developed that help clinicians to decide whether an infection is bacterial, fungal or viral in origin, including: a) microbial culture, the most widely used and accepted method of diagnosing bacterial, and to a lesser extent fungal and viral, infections (though microbiological culture is often time-consuming and is often negative in patients who are receiving antibiotic therapy [4, 5] ); b) serology, including tests to determine the presence of microbial antigens or specific anti-microbial antibody titres; c) standard blood-based laboratory evaluation parameters of bacterial infection, such as leukocyte and neutrophil counts, serum C-Reactive Protein (CRP) levels, and Erythrocyte Sedimentation Rate (ESR), which all possess a relatively poor sensitivity and specificity for microbial infections [6] ; d) the use of inflammatory mediators, such as M-CSF, TNF-α, IL-1, IL-6, and IL-8 to detect infection and identify bacteraemia (a common problem however, is their lack of specificity [7] [8] [9] [10] [11] [12] ); e) the expression of FcRI (CD64) on human neutrophils, which has been proposed as an improved diagnostic test for the evaluation of infection and sepsis as the expression of FcRI on neutrophils and monocytes is increased in both bacterial and viral infections [13] (N.B. its usefulness as a marker for differential diagnosis has been somewhat limited [14] [15] [16] [17] , except from our own research where neutrophil FcγRI was exploited to distinguish between DNA and RNA virus infections [18]); f) the serum level of procalcitonin (PCT) is a potential marker of bacterial infection in critically ill patients (though this analyte appears to be correlated more to the severity of the infection [19, 20] , particularly sepsis [21] , rather than being an unequivocal marker of bacterial infection); and g) the use of nucleic acid amplification technology, including real-time PCR, which has been increasingly applied to detect the presence of specific microbial genes within clinical material, including blood. However, though a highly specific test, many target-specific PCR probes may be needed in order to successfully identify the relevant pathogen involved in an infection, which increases the number of tests that have to be performed per individual sample leading to an increased total cost per diagnosis). However, the sensitivity of the PCR technique is also its weakness. For example, a virus genome may be released from an infected tissue weeks after the actual infection has ended, possibly resulting in a false positive diagnosis.
Clearly then, there is an ongoing need for new sensitive and specific markers of bacterial infection that will help the clinician decide on the usefulness of antimicrobial therapy in patients presenting with systemic disease. One candidate technology that may help in this process is the flow cytometric determination of specific phagocyte surface receptors.
Flow Cytometric Analysis. Flow cytometry is a universally accepted technology used for detecting and counting particular types of cells (0.2 to 150 micrometers) such as immune cells, as well as detecting and quantifying receptors expressed on cellular surfaces. The sample to be tested comprises a suspension of cells which streams through the flow cytometry apparatus towards a point (in a flow chamber) where a beam of light (usually a laser) illuminates the sample. The passage of cells through a light beam generates a scattered and/or fluorescent light signal (via excited fluorescent dyes bound to specific cells) that may be detected by a "forward scatter", or "side scatter", using a fluorescence light detector. Fluctuations in light emission at each detector may be translated into information regarding the physical and chemical characteristics of the cells that have passed through the detector. Flow cytometry is now routinely used in many clinical laboratories, especially in the study of leukaemias. Of particular importance, flow cytometry analysis is a rapid technique, the time window from procuring a sample (e.g. blood), to data handling, being less than one hour (Fig. 1) . For a more complete review of the workings of a flow cytometer, the reader is referred to [22] . In addition, the use of commercially available fluorescent calibration beads, now makes it possible to compare quantitative flow cytometry data between different laboratories, by allowing, for example, the reporting of receptor expression levels as absolute receptor numbers (expressed as the molecules of Equivalent Soluble Fluorochrome (MESF), or as Antigen Binding Capacity (ABC)) [7, 23, 24] .
Phagocytes. Phagocytes are immune cells of the body that include: 1) monocytes -which circulate in the blood; 2) macrophages /dendritic cells -which are found in tissues throughout the body; and 3) neutrophils -which principally circulate in the blood but can move into tissues when required. Further, neutrophils also contain intracellular bodies or granules filled with potent bactericidal chemicals, hence they may also be called "granulocytes". Other granulocyte cells include eosinophils and basophils. For a more complete review of immune cells see [25] .
The major breakthrough in phagocyte research happened over 100 years ago when Nobel prize winner Ilya Mechnikov theorized that certain white blood cells could engulf (phagocytose) and destroy harmful bodies such as bacteria. At that time, neutrophils were at the centre of intensive discussion about the nature of immunity and were considered by many as the most crucial cellular component of the immune system. Against this background, it is rather surprising that in recent immunological textbooks, for example, there are only a few pages dedicated to neutrophils, even though they are the most predominant cells in the blood stream and are the first cells to arrive at the site of infection! In this context, the author's own research group have, for the last 20 years, continued investigating phagocyte function and especially neutrophil function with respect to receptor expression, phagocytosis, and intracellular killing via the "respiratory burst". These studies have been performed in relation to infectious and inflammatory diseases, cancer, atopy and food allergy, as well as in healthy controls [16-18, 26-38]. Our results have been particularly relevant to investigating the processes of innate immunity and (more importantly with respect to this chapter) to clinical differential diagnostic applications.
Pro-Inflammatory Cytokines and Phagocytes in Infection.
During infection, the well-orchestrated interplay between the soluble (humoral) and cellular components of the immune system is regulated by proinflammatory cytokines, as well as by low concentrations of other inflammatory mediators, which include LPS, fMLP, pathogen DNA/RNA fragments, and complement components C3a and C5a. Further, proinflammatory cytokines such as IL-6, IL-1, TNF-, INF-, and IL-8 are produced at the site of tissue injury / infection by a variety of cell types, mostly macrophages, monocytes, fibroblasts, and endothelial cells [39] . These cytokines are the main mediators that facilitate local inflammation and the response to infection, including eventual systemic responses.
Neutrophils are primed both locally and systemically by pro-inflammatory cytokines, as well as by low concentrations of inflammatory mediators such as LPS, fMLP, and complement component C5a [40, 41] . Priming occurs via the binding of inflammatory mediators to specific receptors present on the neutrophil cell surface (many of these mediators prevent neutrophil apoptosis [42]), with mediator binding contributing to amplification of the inflammatory response by prolonging the duration of phagocytoc events. Further, the general opinion is that primed neutrophils are not activated per se, but that their respiratory burst activity, and ability to effectively degranulate intracellular granules, is enhanced in response to subsequent stimuli, such as selectin-and CR3-dependent adhesion of chemo-attracted neutrophils to the vessel wall near the area of inflammation/infection [43] . Many receptors are only weakly expressed on the surface of resting (unprimed) neutrophils, being mainly stored in intracellular specific granules, gelatinase granules, and secretory vesicles [44] . It is the activation of primed neutrophils that leads to: i) the rapid and well-orchestrated degranulation of intracellular granules; and ii) the fusion of vesicles and granules with the plasma membrane, which leads to a quantitative up-regulation cell surface receptors.
INTRODUCTION
Two topics are specially important when treating infectious diseases. First, it is essential to know which micro-organism is causing the infection, and second, it is important to know the patient's immune status in relation to the causative agent. With respect to microorganism detection, the causative agent may be identified using both traditional and modern direct detection techniques, such as bacterial culture and PCRrelated genetic amplification techniques. With respect to patient immunity, the patient's immune status may be determined by measuring his/her humoral (antibody mediated) immunity using a variety of technologies, most of which were established as laboratory tools during the 1980's. These technologies include a variety of immunodiffusion tests, membrane-based Western blot assays and Enzyme Linked Immunosorbent Assays (ELISAs) [1] . Of these, it is the latter ELISA technology that is still most often associated with microbiological research and diagnosis, with individual ELISA test kits having been developed in a wide range of both antibody and antigen-specific test formats. Many of these test kits were developed by largescale manufacturers and have now become successfully introduced into the microbiological market. However, though currently very successful, ELISA technology itself actually possesses some major disadvantages. These include: a) the requirement for a relatively large amount of test material (serum or other body fluid); b) a time-consuming protocol; and c) limitations with respect to the simultaneous testing of several different antigens or antibodies within a single test reaction (i.e. multiplex applications). In recent years however, these technological limitations have been largely overcome by the introduction of a new innovative bead-based immunofluorescence technology, the so-called xMAP  and xTAG  Technology (Luminex Corporation, Austin, Texas, USA). In general, xMAP  technology allows the detection of poly(peptides), (poly)saccharides, oligo-nucleotides, antigens and antibodies, whilst xTAG  technology allows the detection of nucleic acids (including viral genomes). Both technologies utilize a novel approach to overcome the disadvantages associated with ELISA-based test formats, as they both require small volumes of sera (or other body fluids), provide time savings with respect to microbiological diagnosis, and allow multiple antibodies and antigens to be tested simultaneously in the same sample (multiplexing testing is easy to perform). 
THE PRINCIPLE OF LUMINEX TECHNOLOGY
Luminex technology facilitates the use of low sample volumes and multiplex formats via specially designed, color-coded beads or "microspheres". These beads are 5.6 microns in diameter and internally color coded using 2 different fluorophores. By mixing the 2 fluorophores at different intensities, and then filling different batches of beads with the different fluorophore mixes, it is possible to create a set of approximately 100 (100-plex) distinguishable beads, each possessing its own spectral signature. Each of these 100 bead types can then be coated with specific biological materials and combined for multiplex testing applications. The coated beads (currently, antigens are the main biological coating material used) are then mixed with the test analyte e.g. a patient serum sample, so that interactions can take place between the antigen-bead and analyte components (the antigen coated bead is used to specifically capture antibodies present within the sample). After washing, a specific reporter molecule (e.g. a secondary anti-IgG antibody, labelled with a fluorescent dye) is added to the beads in order to detect the presence or absence of bound analyte components (in this case bound antibody) on the bead surface (Fig. 1A) . After re-washing, the beads are analysed using a flow cytometer equipped with two lasers. The first (red) laser excites the internal dyes present within the beads, and the second (green) laser excites the fluorescent dye on the reporter molecule (Fig. 1B) . High-speed digital-signal processors then identify each individually colored bead and determine whether the reporter molecule is attached to the surface of the bead, based on the presence/absence of a fluorescent reporter signal. The results are then reported in "Median Fluorescence Intensity" (MFI) values. Currently, the Luminex  flow cytometer can read 100 different color-coded beads, meaning that theoretically at least 100 different tests can be performed simultaneously on each sample. Further, using a 96-well microtiter plate for the analyses, means that theoretically 100 assays can be performed on 96 samples, producing 9,600 assay results within a very short period of time [2] [3] [4] . 
MEDICAL MICROBIOLOGICAL APPLICATIONS
The majority of current applications for xMAP  and xTAG  bead-based flow cytometry technologies involve human-based research and diagnostics, including protein expression profiling (markers of human disease, cytokine measurement, metabolic markers), the diagnosis of genetic disease (cytochrome p450 and cystic fibrosis), and immunodiagnostics (autoimmune and HLA testing). In contrast, the application of bead-based flow cytometry techniques in medical microbiology research and diagnosis has been demonstrated for relatively fewer applications, though the number of articles published in this field is increasing exponentially. Further, many of these published applications are being directly adapted from the research to the diagnostic microbiology field.
Bead-based flow cytometry technology may be utilised to detect both microbial antigens and microbialdirected antibodies. For example, Luminex  technology may be used for the rapid identification of antigens or oligonucleotide sequences from fungi, parasites and bacteria, including Aspergillus species [5] , Cryptococcus neoformans and Cryptococcus gatti [6] , Salmonella species [7] , Cryptosporidium hominis and Cryptosporidium parvum [8] , vaginal microbiota [9] , Vibrio species [10] , Plasmodium species [11] , Candida albicans, Candida krusei, Candida parapsilosis, Candida glabrata, and Candida tropicalis [12] . Further, with respect to the detection of antibodies, the technique may be useful in measuring the presence or absence of antibodies directed against a wide variety of microorganisms including human papillomavirus [13] , West Nile virus [14] , Mycobacterium tuberculosis [15] [19] , tetanus, diphtheria, Haemophilus influenzae B [20] , Neisseria meningitidis serogroup A, C, Y and W-135 [21] and pneumococcal polysaccharides [22, 23] . Further, new bead-based antibody detection protocols are continually being developed, often involving multiplex applications for the detection of many different microbial antibodies within a single diagnostic experiment (Table 1) . Finally, the use of secondary (detection) antibodies directed against different isotypes of antibody (including antiIgG, anti-IgM, anti-IgA, anti-IgD and anti-IgE), as well as the use of secondary antibodies against immunoglobulin subtypes (anti-IgA1, antiIgG2, anti-IgG4 etc), allows investigations to be performed relating to the development of, for example, the immune response against acute infections, mucosal immunity and the development of antibody subtypes with age.
BEAD-BASED FLOW CYTOMETRY IN MEDICAL MICROBIOLOGICAL RESEARCH
In our own laboratory (Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands), bead-based flow-cytometry technology has been extensively utilized to measure antibodies directed against several major pathogens, including Staphylococcus aureus, Haemophilus influenzae and Moraxella catarrhalis. With respect to S. aureus, we have developed a multiplex assay to simultaneously measure the antibody response to 40 different antigens of S. aureus, including the comparison of anti-staphylococcal antibody levels in healthy persistent carriers versus noncarriers of S. aureus. Although the antibody profiles were quite unique to each individual, we were able to identify characteristic differences in humoral response between these 2 groups [24] . In another investigation, we used the technology to study the anti-S. aureus humoral immune response in a longitudinal collection of sera from young children. Again, we were able to show that antibody profiles varied extensively between individuals, with IgA and IgM levels clearly increasing over the first 2 years after birth and maternal IgG antibodies decreasing steeply during the first six months of life. Additionally, maternal antibody levels did not appear to provide protection against S. aureus colonization, indicating that that several staphylococcal virulence factors are produced during the first confrontation between child and S. aureus [25] . Finally, we compared differences in anti-toxin antibodies generated by individuals suffering from distinct staphylococcal infections (bacteraemia, soft tissue-, respiratory tract-, and joint infections) and in patient controls [26] . Significantly elevated levels of antibodies against many S. aureus toxins were observed in infected patients as opposed to patient controls (Fig. 2) , suggesting that the production of these toxins are at least involved in the pathogenesis of S. aureus infections [26] . The basic methodology utilised in our own research is generally applicable to all medical microbiological research that utilises bead-based cytometry, and is briefly described below (pages 158 -160) in Boxes 1 and 2. The first step involves the 
